Saturday Rounds: Week of August 9–15, 2026

Biotech’s week traded distress for discipline: Sangamo’s bankruptcy auction let PTC Therapeutics pick up a near-approval Fabry gene therapy for a fraction of its original value, Bristol Myers Squibb banked the first-ever approval of a new drug class on a debated surrogate endpoint, and investors…